Improving light stability by configuring active ingredients in the inner core: OSDrC technology and contract formulation development.
<Tablet Sample Presentation> Introducing the improvement of light stability using OSDrC technology! The outer layer's barrier effect protects the active ingredients from light.
The "OSDrC" technology allows for precise and flexible control of the inner core due to its variable double-structure design, enabling the production of high-quality core-containing tablets and facilitating the development of various new dosage forms. By localizing the active ingredient in the inner core and physically protecting it with an outer layer, stability against light is improved. 【Features】 ■ The outer layer can be of any desired thickness. ■ It is possible to produce formulations that place light-sensitive active ingredients in the inner core while positioning light-resistant active ingredients in the outer layer. ◎ Sample Offer ◎ We will send tablet samples made using OSDrC technology to those who request them. Please indicate your request for samples and the quantity in the contact form below. *: Each request includes 2 sheets of PTP packaging for one person (one sheet each for round tablets and oblong tablets). Data demonstrating the protective effect of active ingredients from light using OSDrC technology can be viewed by downloading the PDF below.
Inquire About This Product
basic information
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
Sanwa Chemical Research Institute, as a member of the Suzuken Group focused on health creation, provides services aimed at improving the quality of life (QOL) for people who wish for better health, centered around its two main businesses: "pharmaceuticals" and "diagnostic drugs." In the "pharmaceuticals business," we are steadily building a track record with a focus on new drugs in the areas of diabetes and kidney/dialysis-related fields. In the "diagnostic drugs business," we are continuously developing and launching self-blood glucose meters, sensors, and diagnostic drugs for infectious diseases. Furthermore, by adding two more businesses— the "OSDrC (Osudrack) business" utilizing innovative formulation technology and the "contract manufacturing business" with advanced quality control systems— Sanwa Chemical Research Institute continues to evolve further.
